Publications

Abee M.J., Mawhinney I. (2002)
Economic benefit of simultaneous treatment of subclinically affected quarters in cases of clinical mastitis
World Buiatrics Congress, Hannover

Allan M.J., Fourie N., Thomas E. (2002)
The comparative distribution of cefquinome in milk following intramuscular injection, before and after experimentally induced endotoxic mastitis in dairy cattle.
World Buiatrics Congress, Hannover

Amiridis G, Fthenakis G, Dafopoulos J, Papanikolaou T, Mavrogianni V (2003)
Use of cefquinome for prevention and treatment of bovine endometritis.
J. Vet Pharmacol 26, 387-390

Barker S.A., Kappel L.C., Short C.R. (1994)
Tissue Distribution and Clearance of the Cephalosporin Cefquinome in the Bovine
WBC Bologne

Bertocchi L., Roncada P., Greppi G.F., Bravo R., Belloli A. (200????)
Efficacia di cefquinome nel trattamento delle mastiti da staphiloccoccus aureus nel bovino
Large Animals Review, ????, 31-34

Block Cv, Wanner M, Heinritzi K. (2005)
Einfluss verschiedener Reproduktionsphasen des Sau auf die Pharmakokinetik des Cepjalosporins Cefquinom.
Tieräztl. Umschau 60, 137-145

Böttner A., Schmid P., Humke R. (1995)
In vitro efficacy of cefquinome (INN) and other antiinfective drugs against bovine bacterial isolates from Belgium, France, Germany, The Netherlands and the United Kingdom.
J.Vet.Med. B 42, 377-383

Brasseur D., Buggin M., Viguerie Y., Houffschmitt P. (2002)
Cefquinome in the treatment of septic urogenital disorders in cows
World Buiatrics Congress, Hannover

Deshpande L., Pfaller M., Jones R.N. (2000)
In vitro activity of ceftiofur tested against clinical isolates of Escherichia coli and Klebsiella pneumoniae including extended spectrum β-lactamase producing strains.
International Journal of Antimicrobial Agents 15, 271-275

Drugeon H.B., Thomas E., Schmid P. (2000)
Study of the Bactericidal Activity of Cefquinome on Porcine Bacterial Strains - Abstract.
EAVPT Jerusalem

Ehinger A, Allan M, Hartmann M, Zschiesche E, Thomas E (2005)
Pharmacokinetic aspects of a new dry cow therapy.
Cattle Practive 13 (3), 227-230

Ehinger A, Allan M, Hartmann M, Zschiesche E, Thomas E (2004)
Depletion of residues in edible tissues and milk following treatment with a new cefquinome dry cow formulation.
WBC Quebec

Fraipont J.L., Houffschmitt P., Viguerie Y. (2002)
Cefquinome in the treatment of septic arthritis in calves
World Buiatrics Congress, Hannover

Ganière JP, Manigion C, Péridy M (2004) Détermination des concentrations minimales inhibitrices et bactéricides de la cefquinome, la marbofloxacine, la tylosine et la spiramycine en solution dans du lait vis-à-vis de bactéries isolées de mammites bovines. (English tranlation available)
Revue Méd.Vét. 155, 8-9, 411-416

Gibbs H.A. (1996)
The Efficacy of Cefquinome in the Treatment of Bacterial Infections of the Bovine Foot
WBC Edinburgh

Gibbs H.A., Böttner A. (1994)
The Use of Cefquinome in the Treatment of Respiratory Disease in Cattle
WBC Bologne

Griers P., Houffschmitt P., Guérin-Faublée V. (2002)
Antimicrobial susceptibility of different pathogens isolated from clinical mastitis in French dairy cows.
WBC Hannover

Guérin-Faublée V, Bruchon JF, Houffschmitt P (2005)
Sensibilité aux antibiotiques de colibacilles isolés lors de diarrhées néonatales chez le veau.
Journées Nationales GTV, Nantes

Guérin-Faublée V, Bruchon JF, Houffschmitt P (2002)
Sensibilité aux antibiotiques de colibacilles isolés lors de diarrhées néonatales chez le veau.
SNGTV Tours, May

Guérin-Faublée V., Carret G., Houffschmitt P. (2003)
In vitro activity of 8 antimicrobial agents against bacteria isolated from clinical mastitis in cows
Vet.Rec 152, 466-471

Guérin-Faublée V., Tardy F., Bouveron C., Delignette-Muller L., Carret G. (2002)
Antimicrobial susceptibility of Sreptococcus species isolated from clinical mastitis in dairy cows.
Intern. J. Antimicrob. Agents 19, 219

Heinritzi K, Hagn J. (1999)
Untersuchungen zur Wirksamkeit und Verträglichkeit des neu entwickelten cephalosporins cefquinom bei an puerperaler Septikämie und Toxämie erkranten Sauen.

Tierärtzl. Prax., (translated into english) 27(G), 114-121

Höbarth G, Winter P, Baumgartner W (2004)
Wirksamkeit von Cefquinom in der Behandlung boviner Mastitiden - eine Feldstudie.
Tieräztl. Umschau 59, 718-724

Houffschmitt P, Abee M, Guérin-Faublée V (2004)
Antibiotic susceptibility of Escherichia coli strains isolated from neonatal diarrheic calves.
WBC Quebec

Houffschmitt P, Ehinger A, Thomas E (2005)
Diffusion de la cefquinome dans les tissus de vaches traitées par voie intramammaire au tarissement.
Journées bovines Nantaises

Houffschmitt P., Allan M., Fourie N., Thomas E. (2002)
Distribution de la cefquinome dans le plasma et le lait de vaches à mammite endotoxinique.
SNGTV Tours

Houffschmitt P., Lebreton P., Batut V., Clement H., Laurent J.L. (2002)
Inflammation markers in beef cattle during post partum peritonitis: a follow up after treatment with Cefquinome.
World Buiatrics Congress, Hannover

Houffschmitt P., Skowronski V., Roy O., Thomas E. (2002)
Septicémie néonatale des veaux: efficacité comparée de la cefquinome et de la gentamicine.
SNGTV Tours

Knappstein K, Suhren G, Walte H (2003)
Influence of milking frequency on withdrawal period after application of β-lactam antibiotic-based drugs.
Analytica Chimica Acta 483, 241-249

Lang I., Rose M., Thomas E., Zschiesche E. (2002)
A field study of Cefquinome for the treatment of pigs with respiratory disease
Revue Méd. Vét. 153, 8-9, 575-580

Limbert M., Isert D., Klesel N., Markus A., Seeger K., Seibert G., Schrinner E. (1991)

Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
Antimicrob. Agents Chemother. 35, 14-19

Loehlein W., Radelooff I., Wolf O., Thomas E., Keita A. (2002)

Die kilinsche Wirksamkeit von Cefquinom (Cobactan 2.5% Injektioslösung) in der Behandlung der Epidermitis exsudativa beim Schwein.
Tierärztl.Umschau 57, 367-374

Lohr B, Brunner B, Hellmann K (2004)

Einsatz von Cobactan 2.5% bei Tieren (Rind).
Tieräztl. Umschau 59, 352-355

Lohr B, Brunner B, Hellmann K (2004)

Einsatz von Cobactan 2.5% bei Tieren (Schwein).
Tieräztl. Umschau 59, 356-358

Lohr B, Brunner B, Hellmann K (2004)

Einsatz von Cobactan 2.5% bei Tieren (Pferd).
Tieräztl. Umschau 59, 410-412

Lohr B, Brunner B, Hellmann K (2004)

Einsatz von Cobactan 2.5% bei Tieren (Klein- und Heimtiere).
Tieräztl. Umschau 59, 412-415

Maden M, Tras B, Bas A, Elmas M, Yazar E, Birdane FM (2001)
Investigation of biochemical and haematological side effects of cefquinome in healthy dogs
Vet Quart. 23, 32-34

Möller T., Hofmann W (1997)
Zur Therapie respiratorischer Erkrankungen beim Kalb mit dem cephalosprin cefquinom.

Der prktiche Tierarzt 87 (1), 54-58

Murphy S.P., (1994)

Cefquinome (HR B56). In vitro evaluation of a broad spectrum cephalosporin indicated for infections in animals.
Diagn.Microbiol.Infect.Dis. 20, 49-55

Nai-Xun Chin, Jian-Wei Gu, Wei Fang, Harold C. (1992)
In vitro activity of cefquinome, a new cephalosporin compared with other cephalosporin antibiotics.
Diagn.Microbiol.Infect.Dis. 15, 331-337

Navetat H., Griers P., Lancar R., Espinasse J. (1996)
Efficacité de la cefquinom dans le traitement des bronchopneumonies infictieuses enzootiques des jeunes bovins éléves en lots
Bull GTV 1

Orden J.A., Ruiz-Sante-Quiterria J.A., Garcia S., Cid D., De La Fuente R. (1999)
In vitro activity of cephalosporins and quinolones against Escherichia coli strains isolates from diarrheic dairy calves.
Antimicrobial.Agents and Chemotherapy, ????, 510-513

Petersen I, Swinkels J, Thomas V, Wilhelm C, Allan M. (2006)
Efficacy of Cobactan 7.5% against bovine respiratory disease caused by Histophilus Somni; Pharmacokinetic and pharmacodynamic data.
Proceedings of the World Biuatrics Congress, Nice.

Petersen I, Swinkels J, Zschiesche, E. (2006)
Early assessment of the outcome of treatment with Cobactan 7.5% on naturally occurring Bovine Pneumonia.
Proceedings of the World Buiatrics Congress, Nice.

Petersen I, Swinkels J, Zschiesche E.(2006)
Clinical efficacy of Cobactan 7.5% in the treatment of naturally occurring bovine respiratory disease in Europe. Proceedings of the World Buiatrics Congress, Nice.

Rassbach A., Schimmel D. (1996)
Untersuchungen zur Wirksamkeit von cefquinom gegen eine experimentelle Haemiphilus-parasuis-Infektion bei primären SPF-Ferkeln.
Tierärztl. Umschau 51, 398-402

Rose M, Swinkels J, Allan M, Thomas E, Wilhelm C. (2006)
Pharmacokinetic and Pharmacodynamic aspects of Cobactan 7.5% in cattle. Proceedings of the World Buiatrics Congress, Nice.

Rose M., Schmid P., Böttner A. (1996)
Zur Anwendung von Cefquinom beim Rind : Konzentrationsverlauf im Bronchialsekret und in vitro-Wirksamkeit Pasteurella spp
Tieräarztl. Umschau
51
760-765

Rose M., Schnurrbusch U., Heinritzi K. (1996)
The Use of Cefquinome in the Treatment of Pig Respiratory Disease and MMA Syndrome
IPVS Bologna

Rose M., Thomas V., Nordmann P. (2004)
In vitro activity of thierd and fourth generation cephalosporins against E.coli strains expressing plasmid-encoded AmpC cephalosporinases. Risk Management for the Limitation of Antibiotic Resistance
Scientific Symposium, Federal Office of Consumer Protection and Food safety, Berlin

Rose M., Wissler R., Zschiesche E., Thomas E (2000)
Wiksamkeit und Verträglichkeit des neu entwickelten Cephalosporins Cefquinom bei bakteriellen Atemwegserkrankungen des Schweines.

Tierärzt. Prax.; 28 (G), 331-6

Sader H.S., Jones R.N. (1993)
The fourth generation cephalosporins : antimicrobial activity and spectrum definitions using cefpirome as an example.

The Antimicrobial newsletter 9 (2), sep-16

Schimmel D (1992)
Hinweise zur Prophylaxe respiratorischer Pasteurellainfektionen aufgrund von Ergebnissen experimenteller Immunisierung von Kälbern durch gleichzeitige Verabreichung von cefquinome und P.haemolytica A1
Tierärztl. Umschau 47, 149-153

Schmid P. (1994)
Cobactan ein neues antiinfektivum für die Veterinärmedizin : in vitro Activität und Erfahrungen bei der klinischer Prüfung
Berlin Branderburgischer Rindertag

Schmid P. (2000)
Cephalosporine - Eine Frage der Generation?
Göttingen

Schmid P., Böttner A., Humke R. (1994)
In Vitro Testing of Bacterial Field Strains from Bovine Origin for Sensitivity to Cefquinome
WBC Bologna

Schmid P., Thomas V. (2002)
Cefquinome - eight years antimicrobial susceptibility surveillance in cattle
World Buiatrics Congress, Hannover

Schmidt H., Schmid P. (1996)
Cefquinome (Cobactan®) - Application in Pigs (In-Vitro-Efficacy, Pharmacokinetics, Residual Behaviour)
IPVS Bologna

Schnurrbusch u., Kobera R., Rose M. (1999)
Wirksamkeit der systemischen Antibiose.
BPT Kongress Nürnberg

Schwarzkopf J., Zehle H.H., Garlipp P., Nagy I., Rose M., Steiner A., Willwohl R., Zipperling V., Zschiesche E. (2000)
Cefquinome - a new molecule in the treatment of acute mastitis in dairy cows.
WBC Punta del Este

Schwarzkopf J., Zehle H.H., Garlipp P., Nagy I., Rose M., Steiner A., Willwohl R., Zipperling V., Zschiesche E. (2000)
Cefquinome efficacy on milk yield and somatic cell counts in the treatment of acute mastitis in dairy cows.
WBC Punta del Este

Short C.R, Barker S.A., Kappel L.C., Caprile K.A., Cummings L.E. (1991)
Residue Depletion Profile for Cefquinome in Beef and Dairy Cattle
EAVPT

Shpigel N.Y., Levin D., Winkler M., Saran A., Ziv G., Böttner A. (1997)
Efficacy of cefquinome fopr treatment of cows with mastitis experimentally induced using Escherichia coli.
J. Dairy Sci 80, 813-323

Thomas E, Zschiesche E, Knoppe T (2004)
Efficacy of a new cefquinome dry cow formulation in a controlled, randomized and partially blinded field study.
WBC Quebec

Thomas E., Allan M., Böttner A. (2002)
Pharmacokinetics of Cefquinome in porcine cerebrospinal fluid
International Pig Veterinary Society, Ames

Thomas E., Griers P. (1999)
Study of the Local Tolerance of Intramammary Administration of Cobatan® LC in the Dairy Cow.
SNGTV Nantes

Thomas E., Griers P. (1999)
Tissue and Milk Pharmacokinetics of Cobactan® LC in the Dairy Cow.
SNGTV Nantes

Thomas E., Lang I., Loehlein W., Radeloff I., Wolf O., Keita A., Pommier P., Böttner A. (2002)
Clinical efficacy of Cefquinome in the treatment of exudative epidermitis in pigs.
International Pig Veterinary Society, Ames

Thomas E., Martin G., Voss B., Boettner A., Pommier P., Loehlein W., Hellmann K. (2002)
A comparative field study of the efficacy of cefquinome and amoxycillin against acute meningitis of weaned piglets.
The pig Journal 50, 28-41

Thomas E., Martin G., Voss B., Pommier P., Pagot E., Keita A., Loehlein W., Böttner A. (2002)
A comparative field study of the efficacy of Cefquinome and Amoxycillin against acute meningitis of weaned piglets
International Pig Veterinary Society, Ames, 2-5 June 2002

Thomas E., Rose M., Gibbs A. (2000)
Cefquinome - a multi-site controlled field efficacy study in bovine subacute mastitis.
WBC Punta del Este

Thomas E., Roy O., Zschiesche E., Boettner A., Martin G. (2002)
Comparative efficacy of cefquinome and gentamicin in the treatment of neonatal calves with clinical signs of septicemia.
World Buiatrics Congress, Hannover

Thomas E., Stockhofe-Zurwieden N., Smith H.E. (2000)
Efficacy of Cefquinome (Cobactan® 2,5%) in the Treatment of Streptococcus suis Experimentally Induced Meningitis in Piglets.
EAVPT Jerusalem

Thomas E., Stockhofe-Zurwieden N., Smith H.E., Wisselink H.J., Buijs R.M., (2000)
Efficacy of Cefquinome (Cobactan® 2,5%) in the Treatment of Streptococcus suis Experimentally Induced Meningitis in Piglets.
IPVS Melbourne

Thomas V, Rose M, Wilhelm C, Davies R, Brisabois A (????)
Susceptibility of bovine amoxicillin-resistant Salmonella spp. to beta-lactams antibiotics.

Thomas V, Swinkels J, Rose M, Petersen I. (2006)
Survey of cefquinome susceptibility of Pasteurella multocida and Mannheimia haemolytica isolated from diseased cattle in Europe from 1994-2005.
Proceedings of the World Buiatrics Congress, Nice.

Thomas V, Thomas E (2003)
??????
EAVPT Lisbon

Thomas V., Allan M., Thomas E., Böttner A. (2002)
Activité bactéricide de la cefquinome sur Streptococcus suis dans le liquide céphalorachidien du porc.
2e Colloque International Francophone de Bactériologie Vétérinaire, Ploufragan

Thomas V., Allan M., Thomas E., Schmid P., Böttner A. (2002)
Bactericidal activity of Cefquinome against Streptococcus suis in porcine cerebrospinal fluid
International Pig Veterinary Society, Ames

Thomas V., Thomas E. (2002)
Surveillance pré-et post-marketing de la sensibilité des bactéries pathogènes du porc à la cefquinome.
2e Colloque International Francophone de Bactériologie Vétérinaire, Ploufragan

Williams R.L., Pearson R.B,Hill A.W., Barley J.P., Davies S. (1999)
The Treatment of Sub-Clinical Mastitis in the Young Dairy Cow - A Practical Application?
BCVA

Winter P., Höflechner A., Baumgartner W. (1999)
Zum Resistenzverhalten von ovinen Mastitiserregern (Resistance oattern of ovine mastitis pathogens)
Berl. Münch. Tierärztl. Wschr. 112, 216-222

Zehle H, Möller-Holtkamp P, Garlipp H, Hünniger H (2004)
Praxisorientierte Erfahrungen mit Cefquinom bei der lokalen und kombinierten Mastitistherapie.
Der praktische Tierarzt 85, 9, 658-665

Zehle H, Möller-Holtkamp P, Garlipp H, Hünniger H (2004)
Praxisorientierte Erfahrungen mit Cefquinom bei der lokalen und kombinierten Mastitistherapie.
Der praktische Tierarzt 85, 9, 658-665

Top of page